摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-iodophenyl)benzamide | 52807-28-0

中文名称
——
中文别名
——
英文名称
N-(3-iodophenyl)benzamide
英文别名
——
N-(3-iodophenyl)benzamide化学式
CAS
52807-28-0
化学式
C13H10INO
mdl
MFCD04681254
分子量
323.13
InChiKey
YDSSNARSCZZMIP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (4-(3-ethynylimidazo[1,2-b]pyridazin-6 yl)phenyl)(morpholino)methanone 、 N-(3-iodophenyl)benzamide 在 N-(3-((6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)phenyl)benzamide 、 crude product 、 silica gel 、 methanol-dichloromethane 作用下, 以to afford N-(3-((6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)phenyl)benzamide (20.0 mg, 25%, AUC HPLC 97%) as a yellow solid的产率得到N-(3-((6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)phenyl)benzamide
    参考文献:
    名称:
    BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF
    摘要:
    本发明涉及某些化合物(例如咪唑吡嗪、咪唑吡啶、咪唑吡嗪和咪唑嘧啶化合物),它们作为MAP激酶相互作用激酶MNK2a、MNK2b、MNK1a和MNK1b的抑制剂。本发明还涉及包含这些化合物的制药组合物,并用于预防和治疗疾病(例如增生性疾病(例如癌症)、炎症性疾病、自身免疫性疾病、代谢性疾病和神经退行性疾病(例如自闭症、自闭症谱系障碍、阿尔茨海默病)),以及治疗这些疾病的方法。
    公开号:
    US20160229860A1
点击查看最新优质反应信息

文献信息

  • Monomer containing electron-withdrawing group and electron-donative group, and copolymer and proton-conductive membrane comprising same
    申请人:JSR Corporation
    公开号:EP1245554A1
    公开(公告)日:2002-10-02
    A monomer containing an electron-withdrawing group and an electron-donative group which can be easily controlled in the upper limit of the amount of a sulfonic acid , which impairs the mechanical properties of a copolymer, and can provide a sulfonated polymer that forms a proton-conductive membrane having a high proton conductivity over a wide temperature range, an excellent mechanical strength and an excellent proton conductivity and showing inhibited swelling in hot water and an aqueous solution of methanol, and a copolymer obtained from the monomer. A monomer containing an electron-withdrawing group and an electron-donative group represented by the following general formula (1) : wherein Y represents a iodine atom, chlorine atom or bromine atom; X represents an electron-withdrawing group; B represents an electron-donative group; and Z represents an aryl group having a specific structure or a monovalent condensed ring hydrocarbon group such as naphthyl group.
    一种含有一个抽电子基团和一个负电子基团的单体,该单体可以很容易地控制磺酸的用量上限,而磺酸会损害共聚物的机械性能,并可以提供一种磺化聚合物,该聚合物可以在很宽的温度范围内形成具有高质子传导性、优异的机械强度和优异的质子传导性的质子传导膜,并在热甲醇溶液中表现出抑制溶胀的特性,以及由该单体得到的共聚物。一种单体,含有由下式通式(1)代表的一个电子吸收基团和一个电子疏导基团: 其中 Y 代表碘原子原子或溴原子;X 代表抽电子基团;B 代表弃电子基团;Z 代表具有特定结构的芳基或一价缩合环烃基团,如基。
  • Bicyclic alkyne derivatives and uses thereof
    申请人:Agency for Science, Technology and Research
    公开号:US10544149B2
    公开(公告)日:2020-01-28
    The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prevention and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, autoimmune diseases, metabolic diseases, and neurodegenerative diseases (e.g. autism, autism spectrum disorders, Alzheimer's disease)), as well as methods of treating these diseases.
    本发明涉及作为MAP激酶相互作用激酶MNK2a、MNK2b、MNK1a和MNK1b的抑制剂的某些化合物(例如咪唑吡嗪咪唑吡啶咪唑哒嗪咪唑嘧啶化合物)。本发明进一步涉及包含这些化合物的药物组合物,以及这些化合物用于预防和治疗疾病(如增殖性疾病(如癌症)、炎症性疾病、自身免疫性疾病、代谢性疾病和神经退行性疾病(如自闭症、自闭症谱系障碍、阿尔茨海默病))以及治疗这些疾病的方法。
  • Monomer containing electron-withdrawing group and electron-donative group, and copolymer and proton-conductive membrane comprising same
    申请人:JSR CORPORATION
    公开号:US20020177656A1
    公开(公告)日:2002-11-28
    A monomer containing an electron-withdrawing group and an electron-donative group which can be easily controlled in the upper limit of the amount of a sulfonic acid, which impairs the mechanical properties of a copolymer, and can provide a sulfonated polymer that forms a proton-conductive membrane having a high proton conductivity over a wide temperature range, an excellent mechanical strength and an excellent proton conductivity and showing inhibited swelling in hot water and an aqueous solution of methanol, and a copolymer obtained from the monomer. A monomer containing an electron-withdrawing group and an electron-donative group represented by the following general formula (1): 1 wherein Y represents a iodine atom, chlorine atom or bromine atom; X represents an electron-withdrawing group; B represents an electron-donative group; and Z represents an aryl group having a specific structure or a monovalent condensed ring hydrocarbon group such as naphthyl group.
    一种含有一个抽电子基团和一个供电子基团的单体,该单体可以很容易地控制磺酸的用量上限,该磺酸会损害共聚物的机械性能,可以提供一种磺化聚合物,该聚合物可以在很宽的温度范围内形成具有高质子传导性、优异的机械强度和优异的质子传导性的质子传导膜,并在热甲醇溶液中表现出抑制溶胀的特性,以及由该单体得到的共聚物。一种单体,含有由以下通式(1)表示的一个抽电子基团和一个负电 子基团: 1 其中 Y 代表碘原子原子或溴原子;X 代表抽电子基团;B 代表弃电子基团;Z 代表具有特定结构的芳基或一价缩合环烃基团,如基。
  • Bicyclic Heteroaryl Compounds
    申请人:ARIAD Pharmaceuticals, Inc.
    公开号:US20200231588A1
    公开(公告)日:2020-07-23
    This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
  • US6794480B2
    申请人:——
    公开号:US6794480B2
    公开(公告)日:2004-09-21
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫